By altering the mRNA structure, researchers can create stable, non-immunogenic mRNA through in vitro transcription.

Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

For mRNA decapping by enhancing DCP2's mRNA-binding affinity and regulating distinct biological processes through DCP1a and DCP1b, human DCP1 is essential.

Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

And this is precisely where the scientists's new strategy comes in. Based on the structure of the mRNA-binding protein, they have developed a large peptide, that can block the interaction of the ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

And this is precisely where the scientists' new strategy comes in. Based on the structure of the mRNA-binding protein, they have developed a large peptide that can block the interaction of the ...

Drug maker Moderna, Inc. (MRNA) reported Thursday that its third-quarter net income was $13 million, compared to a net loss of $3.63 ...

and continuing to reduce our cost structure,” said Stephane Bancel, Chief Executive Officer of Moderna (MRNA). Published first on TheFly – the ultimate source for real-time, market-moving breaking ...